Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887–904.

Article  CAS  PubMed  Google Scholar 

Wan S, Kuo N, Kryczek I, Zou W, Welling TH. Myeloid cells in hepatocellular carcinoma. Hepatology. 2015;62:1304–12.

Article  PubMed  Google Scholar 

Wu C, Lin J, Weng Y, Zeng D-N, Xu J, Luo S, et al. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. J Clin Investig. 2020;130:4679–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prendeville H, Lynch L. Diet, lipids, and antitumor immunity. Cell Mol Immunol. 2022;19:432–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mantovani A, Marchesi F, Jaillon S, Garlanda C, Allavena P. Tumor-associated myeloid cells: diversity and therapeutic targeting. Cell Mol Immunol. 2021;18:566–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218:e20201606.

Article  CAS  PubMed  Google Scholar 

Goossens P, Rodriguez-Vita J, Etzerodt A, Masse M, Rastoin O, Gouirand V, et al. Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression. Cell Metab. 2019;29:1376–89.e4.

Article  CAS  PubMed  Google Scholar 

Van Den Bossche J, O’Neill LA, Menon D. Macrophage immunometabolism: where are we (Going)? Trends Immunol. 2017;38:395–406.

Article  PubMed  Google Scholar 

Rabold K, Aschenbrenner A, Thiele C, Boahen CK, Schiltmans A, Smit JWA, et al. Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics. J Immunother Cancer. 2020;8:e000638.

Article  PubMed  PubMed Central  Google Scholar 

Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 2019;20:137–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee-Rueckert M, Lappalainen J, Kovanen PT, Escola-Gil JC. Lipid-laden macrophages and inflammation in atherosclerosis and cancer: an integrative view. Front Cardiovasc Med. 2022;9:777822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krahmer N, Farese RV, Walther TC. Balancing the fat: lipid droplets and human disease. EMBO Mol Med. 2013;5:973–83.

Article  PubMed  Google Scholar 

Masetti M, Carriero R, Portale F, Marelli G, Morina N, Pandini M, et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2022;219:e20210564.

Article  CAS  PubMed  Google Scholar 

Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 2022;82:3291–306.

Article  CAS  PubMed  Google Scholar 

Su P, Wang Q, Bi E, Ma X, Liu L, Yang M, et al. Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res. 2020;80:1438–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Conza G, Tsai C-H, Gallart-Ayala H, Yu Y-R, Franco F, Zaffalon L, et al. Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity. Nat Immunol. 2021;22:1403–15.

Article  PubMed  PubMed Central  Google Scholar 

Marelli G, Morina N, Portale F, Pandini M, Iovino M, Di Conza G, et al. Lipid-loaded macrophages as new therapeutic target in cancer. J Immunother Cancer. 2022;10:e004584.

Article  PubMed  PubMed Central  Google Scholar 

Wu H, Han Y, Rodriguez Sillke Y, Deng H, Siddiqui S, Treese C, et al. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. EMBO Mol Med. 2019;11:e10698.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.

Article  CAS  PubMed  Google Scholar 

Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–14.

Article  PubMed  Google Scholar 

Ning W-R, Jiang D, Liu X-C, Huang Y-F, Peng Z-P, Jiang Z-Z, et al. Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma. J Clin Investig. 2022;132:e153110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen D-P, Ning W-R, Jiang Z-Z, Peng Z-P, Zhu L-Y, Zhuang S-M, et al. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma. J Hepatol. 2019;71:333–43.

Article  CAS  PubMed  Google Scholar 

Lu L-G, Zhou Z-L, Wang X-Y, Liu B-Y, Lu J-Y, Liu S, et al. PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma. Gut. 2022;71:2551–60.

Article  CAS  PubMed  Google Scholar 

Peng Z-P, Jiang Z-Z, Guo H-F, Zhou M-M, Huang Y-F, Ning W-R, et al. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma. J Hepatol. 2020;73:906–17.

Article  CAS  PubMed  Google Scholar 

Li Z, Wang Y, Xing R, Zeng H, Yu X-J, Zhang Y, et al. Cholesterol efflux drives the generation of immunosuppressive macrophages to promote the progression of human hepatocellular carcinoma. Cancer Immunol Res. 2023;11:1400–13.

Article  CAS  PubMed  Google Scholar 

Jaitin DA, Adlung L, Thaiss CA, Weiner A, Li B, Descamps H, et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell. 2019;178:686–98.e14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuang D-M, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol. 2011;54:948–55.

Article  CAS  PubMed  Google Scholar 

Ogretmen B. Sphingolipid metabolism in cancer signaling and therapy. Nat Rev Cancer. 2018;18:33–50.

Article  CAS  PubMed  Google Scholar 

Liu X, Hartman CL, Li L, Albert CJ, Si F, Gao A, et al. Reprogramming lipid metabolism prevents effector T-cell senescence and enhances tumor immunotherapy. Sci Transl Med. 2021;13:eaaz6314.

Article  CAS  PubMed